ZoomRx

ZoomRx — Longitudinal HCP promotional-response panel: aided/unaided message recall captured 2-7 days after each rep interaction and re-validated at two weeks, tied to the specific promotion, channel (personal, digital, non-personal) and visual aid shown, then joined to real-world prescribing. Includes voice-first qualitative responses (Dynamic Dialogues), phrase-level engagement annotations (Message Highlighter), and a prediction benchmark library of 20M+ message-outcome pairs (Message Labs).. Mid-large specialist: ~550 employees, ~$64.3M revenue, Cambridge, Massachusetts, with an ownership e…

ZoomRx offers (Alternative, Sentiment, Fundamental) — 20M+ message-benchmark records (stated on the page) plus, at a conservative 30-90 seconds per voice response, roughly 0.5-3M hours of HCP spoken audio with paired transcripts accumulated across the program's life. Basis: the 20M+ figure is the vendor's own benchmark count; audio volume derived from the voice-first modality applied to a fraction of those interactions..

Three distinct buyer families: (1) life-sciences commercial — sales-force effectiveness, message optimization, channel-mix ROI and launch tracking; (2) machine-learning — rare medical-professional speech corpus with transcripts for ASR/medical voice models, phrase-level engagement labels for persuasive-text and ad-copy ranking models, and 20M+ stimulus-outcome pairs for preference/reward modeling of messaging; (3) advertising science — attention and recall ground truth usable for generalizable models of how message structure drives retention.

The data is with 11 years of history.

Coverage spans US, UK; Pharmaceuticals, Marketing; alternative, sentiment, fundamental; equities.